ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Mark L. Fuerst

Mark L. Fuerst

Mark L. Fuerst is a freelance health and medical writer for ConsultantLive, Rheumatology Network, Psychiatric Times, and other UBM publications. He writes about rheumatology, psychiatry, neurology, endocrinology, oncology, and men’s health.

Posts by Author

Significant racial and gender-based disparities exist in outcomes among patients with squamous cell carcinoma of the anus, with black men having the lowest survival rates, according to a new study.

Men with non-metastatic prostate cancer who receive androgen deprivation therapy risk loss of bone mineral density and fractures, but both bisphosphonates and denosumab can improve their bone health.

Study authors propose a new asthma patient “phenotype” in which a previous severe event is the sole predictor of another one.

Results of a recent study into the role of lipids in atopic asthma could help identify new targets for therapy.

Patients with primary immunodeficiency diseases are at increased risk of certain cancers, according to a new study. The strongest association was with lymphoma.

More privately insured cancer patients seeking to participate in clinical trials received approval since the passage of the Affordable Care Act, according to a new study.

The FDA has expanded the indication for a scalp cooling device that reduces hair loss during chemotherapy.

Holocaust survivors have a small but consistent increase in the risk of developing cancer, in particular colorectal and lung cancers.

New research suggests it’s possible to reverse the metabolic impact of childhood obesity and avert T2DM in adulthood.

Among the clues revealed in 3 recent studies: brain amyloid, saliva biomarkers, and microvascular dysfunction.

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.